Jan. 8, 2018—Inova Diagnostics announced the clearance of Quanta Flash Calprotectin by the FDA. Quanta Flash Calprotectin aids in the diagnosis of inflammatory bowel disease and helps differentiate IBD from irritable bowel syndrome. The assay provides precise quantification, with an analytical measurement range of up to 3,500 mg/kg, is available on Bio-Flash, a random access chemiluminescent instrument, and can be run simultaneously with other Quanta Flash assays. It is the first fully automated, random access calprotectin assay available in the U.S.
Tagged with: Inova Diagnostics---